We are live on ! Find out more
MTACU

MedTech Acquisition Corporation Unit
MTACU

Delisted

MTACU was delisted on the 10th of August, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of MTACU yet.

MTACU Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in MedTech Acquisition Corporation Unit (MTACU) for Q3 2023, worth a combined $0 — down 100% from $1.35K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of MTACU and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $1.32K sold.

  • 0 institutional investors held MedTech Acquisition Corporation Unit (MTACU) as of Q3 2023, down from 4 in Q2 2023.
  • Funds reported $0 of MedTech Acquisition Corporation Unit stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new MedTech Acquisition Corporation Unit positions in Q3 2023 and 4 closed out, a net change of -4 holders.
  • The largest MedTech Acquisition Corporation Unit seller in Q3 2023 was Tower Research Capital (TRC), an estimated $1.32K sold.

Based on aggregated 13F filings for Q3 2023.